Edwards Lifesciences (EW) Stock: Charts & Financials

Edwards Lifesciences Corporation (EW)EWEdwards Lifesciences Corporation

About Edwards Lifesciences Corporation

Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. With operations spanning the United States, Europe, Japan, and various international territories, the company offers a comprehensive suite of solutions. Their structural heart disease portfolio encompasses transcatheter heart valve replacement systems designed for minimally invasive procedures, as well as transcatheter repair and replacement options specifically targeting mitral and tricuspid valve pathologies, exemplified by their PASCAL and Cardioband systems. Additionally, they provide advanced surgical structural heart solutions, including the INSPIRIS aortic surgical valve, the KONECT RESILIA pre-assembled aortic tissue valved conduit for complex valve, root, and ascending aorta replacements, and the HARPOON Beating Heart Mitral Valve Repair System for patients suffering from degenerative mitral regurgitation. In the realm of critical care, Edwards supplies advanced hemodynamic monitoring systems that assess patients' cardiac function and fluid status in both surgical and intensive care environments. This offering also features the Acumen Hypotension Prediction Index software, which provides early alerts to clinicians regarding potential dangerously low blood pressure. The company distributes its products to healthcare providers through a combination of its proprietary sales force and independent distributor networks. Founded in 1958, Edwards Lifesciences Corporation maintains its headquarters in Irvine, California.

Irvine, CA

16,000 employees

www.edwards.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Bernard J. Zovighian

View full financials

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	6.51B	1.74B	1.65B	1.57B	1.55B	1.53B	1.41B	1.39B	1.35B
Cost of Goods Sold	1.44B	390.60M	359.30M	340.60M	345.20M	342.60M	301.60M	292.20M	262.90M
Gross Profit	5.08B	1.35B	1.29B	1.23B	1.21B	1.19B	1.11B	1.09B	1.09B
Gross Profit Margin	78.0%	77.6%	78.2%	78.3%	77.9%	77.6%	78.7%	78.9%	80.6%
Total Operating Expenses	3.25B	830.90M	774.60M	858.70M	784.50M	758.70M	716.30M	781.00M	740.90M
Research & Development	1.09B	278.90M	263.30M	267.70M	280.70M	276.20M	254.60M	271.10M	253.40M
Selling, General & Administrative	2.20B	561.20M	522.20M	602.90M	514.60M	502.00M	465.70M	491.90M	421.40M
Operating Income (EBIT)	1.83B	519.50M	514.70M	370.30M	425.10M	430.90M	394.80M	312.60M	350.60M
Operating Margin	28.1%	29.8%	31.2%	23.6%	27.4%	28.1%	27.9%	22.6%	25.9%
Income Before Tax (EBT)	1.42B	519.80M	459.00M	90.40M	348.40M	400.20M	433.90M	390.10M	402.80M
Interest Income	138.00M	30.00M	33.50M	35.90M	38.60M	37.40M	19.50M	44.20M	23.50M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Other Income/Expense	-412.00M	300K	-55.70M	-279.90M	-76.70M	-30.70M	39.10M	77.50M	52.20M
Net Income	1.00B	241.90M	380.70M	91.20M	291.10M	329.80M	358.00M	385.60M	3.07B
Income Tax Expense	439.00M	278.40M	78.30M	26.20M	56.10M	64.30M	70.30M	45.10M	40.70M
Net Profit Margin	15.4%	13.9%	23.1%	5.8%	18.7%	21.5%	25.3%	27.8%	226.7%
EBITDA	2.00B	562.20M	555.60M	413.00M	464.30M	469.00M	431.40M	355.20M	385.10M
EBITDA Margin	30.6%	32.3%	33.7%	26.3%	29.9%	30.6%	30.5%	25.6%	28.4%
Depreciation & Amortization	165.50M	42.70M	40.90M	42.70M	39.20M	38.10M	36.60M	42.60M	34.50M
EPS Basic	1.74	0.42	0.66	0.16	0.50	0.57	0.61	0.65	5.14
EPS Diluted	1.74	0.42	0.66	0.16	0.50	0.56	0.61	0.65	5.13
Shares Outstanding	576.40M	576.40M	579.20M	580.40M	584.70M	587.00M	586.90M	589.80M	597.20M
Diluted Shares Outstanding	577.60M	577.60M	580.70M	581.80M	585.70M	587.90M	587.80M	590.50M	598.10M

Quarterly Report

TTM

Quarter ended Jun 2026

Quarter ended Mar 2026

Quarter ended Dec 2025

Quarter ended Sep 2025

Quarter ended Jun 2025

Quarter ended Mar 2025

Quarter ended Dec 2024

Quarter ended Sep 2024

Revenue

6.51B

1.74B

1.65B

1.57B

1.55B

1.53B

1.41B

1.39B

1.35B

Cost of Goods Sold

1.44B

390.60M

359.30M

340.60M

345.20M

342.60M

301.60M

292.20M

262.90M

Gross Profit

5.08B

1.35B

1.29B

1.23B

1.21B

1.19B

1.11B

1.09B

Gross Profit Margin

78.0%

77.6%

78.2%

78.3%

77.9%

77.6%

78.7%

78.9%

80.6%

Total Operating Expenses

3.25B

830.90M

774.60M

858.70M

784.50M

758.70M

716.30M

781.00M

740.90M

Research & Development

1.09B

278.90M

263.30M

267.70M

280.70M

276.20M

254.60M

271.10M

253.40M

Selling, General & Administrative

2.20B

561.20M

522.20M

602.90M

514.60M

502.00M

465.70M

491.90M

421.40M

Operating Income (EBIT)

1.83B

519.50M

514.70M

370.30M

425.10M

430.90M

394.80M

312.60M

350.60M

Operating Margin

28.1%

29.8%

31.2%

23.6%

27.4%

28.1%

27.9%

22.6%

25.9%

Income Before Tax (EBT)

1.42B

519.80M

459.00M

90.40M

348.40M

400.20M

433.90M

390.10M

402.80M

Interest Income

138.00M

30.00M

33.50M

35.90M

38.60M

37.40M

19.50M

44.20M

23.50M

Interest Expense

N/A

Other Income/Expense

-412.00M

300K

-55.70M

-279.90M

-76.70M

-30.70M

39.10M

77.50M

52.20M

Net Income

1.00B

241.90M

380.70M

91.20M

291.10M

329.80M

358.00M

385.60M

3.07B

Income Tax Expense

439.00M

278.40M

78.30M

26.20M

56.10M

64.30M

70.30M

45.10M

40.70M

Net Profit Margin

15.4%

13.9%

23.1%

5.8%

18.7%

21.5%

25.3%

27.8%

226.7%

EBITDA

2.00B

562.20M

555.60M

413.00M

464.30M

469.00M

431.40M

355.20M

385.10M

EBITDA Margin

30.6%

32.3%

33.7%

26.3%

29.9%

30.6%

30.5%

25.6%

28.4%

Depreciation & Amortization

165.50M

42.70M

40.90M

42.70M

39.20M

38.10M

36.60M

42.60M

34.50M

EPS Basic

1.74

0.42

0.66

0.16

0.50

0.57

0.61

0.65

5.14

EPS Diluted

1.74

0.42

0.66

0.16

0.50

0.56

0.61

0.65

5.13

Shares Outstanding

576.40M

579.20M

580.40M

584.70M

587.00M

586.90M

589.80M

597.20M

Diluted Shares Outstanding

577.60M

580.70M

581.80M

585.70M

587.90M

587.80M

590.50M

598.10M

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	6.07B	5.44B	5.01B	5.38B	5.23B	4.39B	4.35B	3.72B
Cost of Goods Sold	1.33B	1.12B	1.04B	1.17B	1.23B	1.10B	1.16B	922.10M
Gross Profit	4.74B	4.32B	3.97B	4.22B	4.01B	3.29B	3.19B	2.80B
Gross Profit Margin	78.1%	79.5%	79.3%	78.3%	76.6%	74.9%	73.4%	75.2%
Total Operating Expenses	3.10B	2.94B	2.55B	2.51B	2.40B	1.99B	1.99B	1.71B
Research & Development	1.08B	1.05B	962.90M	945.20M	903.10M	760.70M	752.70M	622.20M
Selling, General & Administrative	2.09B	1.79B	1.58B	1.57B	1.49B	1.23B	1.24B	1.09B
Operating Income (EBIT)	1.64B	1.38B	1.43B	1.70B	1.61B	1.30B	1.20B	1.09B
Operating Margin	27.0%	25.3%	28.5%	31.6%	30.8%	29.5%	27.6%	29.3%
Income Before Tax (EBT)	1.27B	1.55B	1.37B	1.77B	1.70B	916.70M	1.17B	761.40M
Interest Income	148.40M	120.30M	67.20M	35.50M	17.40M	23.40M	32.20M	32.00M
Interest Expense	N/A	19.80M	17.60M	26.20M	24.80M	22.20M	27.30M	33.40M
Other Income/Expense	-363.30M	169.40M	-54.90M	65.00M	91.60M	-379.30M	-31.40M	-330.90M
Net Income	1.07B	4.17B	1.40B	1.52B	1.50B	823.40M	1.05B	722.20M
Income Tax Expense	216.90M	152.10M	152.40M	245.50M	198.90M	93.30M	119.60M	39.20M
Net Profit Margin	17.7%	76.7%	28.0%	28.3%	28.7%	18.8%	24.1%	19.4%
EBITDA	1.79B	1.53B	1.57B	1.87B	1.77B	1.43B	1.31B	1.17B
EBITDA Margin	29.5%	28.2%	31.4%	34.7%	33.9%	32.6%	30.2%	31.4%
Depreciation & Amortization	156.60M	155.20M	144.90M	166.80M	163.30M	135.40M	114.60M	77.40M
EPS Basic	1.84	6.98	2.31	2.46	2.41	1.32	1.68	1.15
EPS Diluted	1.83	6.97	2.30	2.44	2.38	1.30	1.64	1.13
Shares Outstanding	584.80M	597.70M	606.70M	619.00M	623.30M	622.60M	624.90M	627.60M
Diluted Shares Outstanding	585.80M	599.30M	609.40M	624.20M	631.20M	631.90M	636.60M	640.80M

Annual Report

12/31/2025

12/31/2024

12/31/2023

12/31/2022

12/31/2021

12/31/2020

12/31/2019

12/31/2018

Revenue

6.07B

5.44B

5.01B

5.38B

5.23B

4.39B

4.35B

3.72B

Cost of Goods Sold

1.33B

1.12B

1.04B

1.17B

1.23B

1.10B

1.16B

922.10M

Gross Profit

4.74B

4.32B

3.97B

4.22B

4.01B

3.29B

3.19B

2.80B

Gross Profit Margin

78.1%

79.5%

79.3%

78.3%

76.6%

74.9%

73.4%

75.2%

Total Operating Expenses

3.10B

2.94B

2.55B

2.51B

2.40B

1.99B

1.71B

Research & Development

1.08B

1.05B

962.90M

945.20M

903.10M

760.70M

752.70M

622.20M

Selling, General & Administrative

2.09B

1.79B

1.58B

1.57B

1.49B

1.23B

1.24B

1.09B

Operating Income (EBIT)

1.64B

1.38B

1.43B

1.70B

1.61B

1.30B

1.20B

1.09B

Operating Margin

27.0%

25.3%

28.5%

31.6%

30.8%

29.5%

27.6%

29.3%

Income Before Tax (EBT)

1.27B

1.55B

1.37B

1.77B

1.70B

916.70M

1.17B

761.40M

Interest Income

148.40M

120.30M

67.20M

35.50M

17.40M

23.40M

32.20M

32.00M

Interest Expense

N/A

19.80M

17.60M

26.20M

24.80M

22.20M

27.30M

33.40M

Other Income/Expense

-363.30M

169.40M

-54.90M

65.00M

91.60M

-379.30M

-31.40M

-330.90M

Net Income

1.07B

4.17B

1.40B

1.52B

1.50B

823.40M

1.05B

722.20M

Income Tax Expense

216.90M

152.10M

152.40M

245.50M

198.90M

93.30M

119.60M

39.20M

Net Profit Margin

17.7%

76.7%

28.0%

28.3%

28.7%

18.8%

24.1%

19.4%

EBITDA

1.79B

1.53B

1.57B

1.87B

1.77B

1.43B

1.31B

1.17B

EBITDA Margin

29.5%

28.2%

31.4%

34.7%

33.9%

32.6%

30.2%

31.4%

Depreciation & Amortization

156.60M

155.20M

144.90M

166.80M

163.30M

135.40M

114.60M

77.40M

EPS Basic

1.84

6.98

2.31

2.46

2.41

1.32

1.68

1.15

EPS Diluted

1.83

6.97

2.30

2.44

2.38

1.30

1.64

1.13

Shares Outstanding

584.80M

597.70M

606.70M

619.00M

623.30M

622.60M

624.90M

627.60M

Diluted Shares Outstanding

585.80M

599.30M

609.40M

624.20M

631.20M

631.90M

636.60M

640.80M

Income Statement

Quarterly Income Statement (USD)

Annual Income Statement (USD)